Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $224,558 - $259,808
-6,217 Reduced 2.48%
244,415 $8.97 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $1.41 Million - $1.84 Million
-35,862 Reduced 12.52%
250,632 $10.2 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $272,919 - $356,266
-6,537 Reduced 2.23%
286,494 $14.7 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $802,252 - $979,348
-18,333 Reduced 5.89%
293,031 $12.8 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $608,054 - $720,961
13,068 Added 4.38%
311,364 $16.3 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $301,812 - $373,983
6,597 Added 2.26%
298,296 $15.4 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $616,205 - $913,421
14,913 Added 5.39%
291,699 $17.2 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $668,898 - $859,257
17,042 Added 6.56%
276,786 $11.9 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $93,222 - $105,605
-2,596 Reduced 0.99%
259,744 $10.2 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $15,472 - $17,449
-462 Reduced 0.18%
262,340 $9.51 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $438,323 - $557,365
-13,096 Reduced 4.75%
262,802 $9.67 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $77,946 - $91,448
-2,455 Reduced 0.88%
275,898 $10.1 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $306,922 - $372,342
-10,190 Reduced 3.53%
278,353 $9.1 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $285,788 - $408,329
-10,573 Reduced 3.53%
288,543 $9.42 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $131,087 - $148,767
3,982 Added 1.35%
299,116 $11.7 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $122,909 - $159,377
-3,783 Reduced 1.27%
295,134 $10.6 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $231,790 - $260,247
-6,268 Reduced 2.05%
298,917 $12.9 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $206,812 - $227,218
5,515 Added 1.84%
305,185 $13 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $270,674 - $308,598
-7,036 Reduced 2.29%
299,670 $13.1 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $146,014 - $177,107
-4,236 Reduced 1.36%
306,706 $13.5 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $298,304 - $318,022
-9,045 Reduced 2.83%
310,942 $11.3 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $188,460 - $218,640
-5,906 Reduced 1.81%
319,987 $11.4 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $892,532 - $947,007
-26,835 Reduced 7.61%
325,893 $11.8 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $10.9 Million - $12 Million
352,728
352,728 $12.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.